ALAFI Capital Co. LLC, 10% Owner at Intra-Cellular Therapies, Inc. (ITCI), bought 3,664 shares at $14.23 ($52K) on 2014-11-18, disclosed to the SEC on 2014-11-18.
Open-market purchase of $52k ITCI by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.07 | 133 | $2K | 3.8% |
| 2 | $14.23 | 3,531 | $50K | 96.2% |
| Total | $14.26 avg | 3,664 | $52K | 100% |
| Filing → |
| ITCI | BUY | 2016-11-17 | $493K | — | Filing → |
| ITCI | BUY | 2014-12-03 | $21K | — | Filing → |
| ITCI | BUY | 2014-11-28 | $516K | — | Filing → |